Pentoxifylline (PTX) is a synthetic dimethylxanthine derivative that modulates the rheological properties of blood and also has both anti-oxidant and anti-inflammatory properties. Although originally developed to treat intermittent claudication, a form of exertion-induced leg pain common in patients with peripheral arterial disease, PTX has been investigated...
Pentoxifylline is indicated for the treatment of intermittent claudication in patients with chronic occlusive arterial disease. Pentoxifylline may improve limb function and reduce symptoms but cannot replace other therapies such as surgical bypass or removal of vascular obstructions.
Cibimi - Hgz 83 Imss, Morelia, Michoacán, Mexico
James A. Haley Veterans' Hospital, Tampa, FL, Tampa, Florida, United States
Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur, Georgia, United States
Edward Hines Jr. VA Hospital, Hines, IL, Hines, Illinois, United States
El Galaa Teaching hosptial, Cairo, Ghamra, Egypt
Brooke Army Medical Center, San Antonio, Texas, United States
University of Alabama at Birmingham, Birmingham, Alabama, United States
University of Washington, Seattle, Washington, United States
New York Center for Orthognathic and Maxillofacial Surgery, Lake Success, New York, United States
Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of
Department of General Surgery, Anhui Provincial Hospital Affiliated with Anhui Medical University, HeFei, Anhui, China
University of Miami Crohn's and Colitis Center, Miami, Florida, United States
Hôpitaux Civils de Colmar, Colmar, France
Institut Daniel Hollard, Grenoble, France
CLCC Saint Etienne, Saint-Priest en Jarez, France
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.